FDA inspection
National Cancer Institute, Cancer Therapy Evaluation Program: FDA inspection ending Jan 10, 2020
FDA inspection 1118260 · No Action Indicated (NAI) · Bethesda, MD
Key facts
| Inspection ID | 1118260 |
|---|---|
| Firm | National Cancer Institute, Cancer Therapy Evaluation Program |
| FEI number | 3010830399 |
| Address | 9609 Medical Center Dr |
| City | Bethesda |
| State | MD |
| ZIP | 20892 |
| Country | United States |
| Fiscal year | 2020 |
| Inspection end date | Jan 10, 2020 |
| Classification | No Action Indicated (NAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data